|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash on hand and in banks | ||||||||||||||||||||
| Interest earning deposits | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities available for sale, at fair value, net (amortized cost of $1,020,125 and $647,505, respectively) | ||||||||||||||||||||
| Investment securities held to maturity, at amortized cost, net (fair value of $607,782 and $625,287, respectively) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Total investment securities | ||||||||||||||||||||
| Debt Securities, Available-for-Sale and Held-to-Maturity, after Allowance for Credit Loss, Total | ||||||||||||||||||||
| Loans receivable | ||||||||||||||||||||
| Allowance for credit losses on loans | ||||||||||||||||||||
| Loans receivable, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Federal Home Loan Bank stock, at cost | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Noninterest-Bearing Deposit Liabilities | ||||||||||||||||||||
| Interest-Bearing Deposit Liabilities | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Deposits held for sale | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Junior subordinated debentures | ||||||||||||||||||||
| Securities sold under agreement to repurchase | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, no par value, 2,500,000 shares authorized; no shares issued and outstanding, respectively | ||||||||||||||||||||
| Common stock, no par value, 50,000,000 shares authorized; 40,906,122 and 33,963,500 shares issued and outstanding, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Debt Securities, Available-for-sale, Amortized Cost | ||||||||||||||||||||
| Total investment securities | ||||||||||||||||||||
| Common Stock, Shares, Outstanding | ||||||||||||||||||||
| Other Real Estate, Foreclosed Assets, and Repossessed Assets | ||||||||||||||||||||
Loading...
